0001209191-23-026733.txt : 20230502 0001209191-23-026733.hdr.sgml : 20230502 20230502185007 ACCESSION NUMBER: 0001209191-23-026733 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230501 FILED AS OF DATE: 20230502 DATE AS OF CHANGE: 20230502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Perrin Steven CENTRAL INDEX KEY: 0001824545 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36620 FILM NUMBER: 23881050 MAIL ADDRESS: STREET 1: C/O ANELIXIS THERAPEUTICS, INC. STREET 2: 1500 DISTRICT AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eledon Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001404281 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 19900 MACARTHUR BLVD. STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 949-238-8090 MAIL ADDRESS: STREET 1: 19900 MACARTHUR BLVD. STREET 2: SUITE 550 CITY: IRVINE STATE: CA ZIP: 92612 FORMER COMPANY: FORMER CONFORMED NAME: Novus Therapeutics, Inc. DATE OF NAME CHANGE: 20170511 FORMER COMPANY: FORMER CONFORMED NAME: Tokai Pharmaceuticals Inc DATE OF NAME CHANGE: 20070622 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-01 0 0001404281 Eledon Pharmaceuticals, Inc. ELDN 0001824545 Perrin Steven C/O ELEDON PHARMACEUTICALS, INC. 19900 MACARTHUR BLVD STE. 550 IRVINE CA 92612 1 1 0 0 President 0 Stock Option (right to buy) 2.30 2023-05-01 4 A 0 317147 0.00 A 2033-05-01 Common Stock 317147 317147 D This option represents a right to purchase up to 317,147 shares of Common Stock, which option vests with respect to 79,287 shares on May 1, 2024, and then with respect to 6.25% of the underlying shares quarterly over the three-year period ending May 1, 2027. /s/ Steve Perrin 2023-05-02